Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
JCR Impact Factor (IF) – 1.736
5-Year Impact Factor – 2.135
Index Copernicus  – 168.52
MEiN – 70 pts

ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2019, vol. 28, nr 7, July, p. 961–965

doi: 10.17219/acem/94391

Publication type: original article

Language: English

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Biodegradable airway stents: Novel treatment of airway obstruction in children

Andrzej Zając1,A,B,C,D,E, Mirosław Krysta1,C, Aleksandra Kiszka1,B, Wojciech Górecki1,F

1 Department of Pediatric Surgery, University Children’s Hospital, Jagiellonian University, Poland


Background. Tracheobronchomalacia is the most common cause of congenital airway obstruction in infants. An alternative for surgical approach (aortopexy) can be metallic airway stents. Usually, they are not considered as a first choice because of the relatively high risk of complications. Recent years have brought encouraging reports of biodegradable stents applied in children.
Objectives. The aim of this study was to report our experience in the treatment of airway malacia using biodegradable stents.
Material and Methods. Six polydioxanone (PDS), self-expanding custom-made stents (ELLA-CS) were implanted in 2 children: 3 in the patient with left main bronchus occlusion due to postpnemonectomy syndrome and 3 stents in the baby with tracheomalacia.
Results. Airway collapse was always relieved after stent expansion. Both patients needed repeated stenting because of limited stent lifespan. All the stents were implanted without complications through a rigid bronchoscope. The baby with stented main bronchus died because of irreversible lung lesion.
Conclusion. This small study shows that biodegradable airway stents seem to be an attractive option in the treatment of tracheobronchomalacia in children. We consider this method to be safe, effective, repeatable, and reversible in small children with growing airways. As a time-buying procedure they can be especially useful in the treatment of tracheobronchomalacia.

Key words

biodegradable airway stents, tracheobronchomalacia, airway obstruction

References (18)

  1. Dutau H, Breen D, Bugalho A, et al. Current practice of airway stenting in the adult population in Europe: A survey of the European Association of Bronchology and Interventional Pulmonology (EABIP). Respiration. 2018;95(1):44–54.
  2. Anton-Pacheco JL. Tracheobronchial stents in children. Semin Pediatr Surg. 2016;25(3):179–185.
  3. Dhar A, Topping J, Johns E, O’Neill D. Biodegradable stents in refractory benign oesophageal strictures – first report of 4 patients from UK. Gastrointest Endosc. 2009;69(5):254–255.
  4. Petrtyl J, Bruha R, Horak L, Zadorova Z, Laash HU. Management of benign intrahepatic bile duct strictures: Initial experience with polydioxanone biodegradable stents. Endoscopy. 2010;42(Suppl 2): E89–90.
  5. Kemppainen E, Talja M, Riihela M, Pohjonen T, Tormala P, Alfthan O. A bioresorbable urethral stent. An experimental study. Urol Res. 1993;21(3):235–238.
  6. Lim LH, Cotton RT, Azizkhan RG, Wood RE, Cohen AP, Rutter MJ. Complications of metallic stents in the pediatric airway. Otolaryngol Head Neck Surg. 2004;131(4):355–361.
  7. de Trey LA, Dudley J, Ismail-Koch H, et al. Treatment of severe tracheobronchomalacia: Ten-year experience. Int J Pediatr Otorhino­laryngol. 2016;83:57–62.
  8. Furman RH, Backer CL, Dunham ME, Donaldson J, Mavroudis C, Holinger LD. The use of balloon-expandable metallic stents in the treatment of pediatric tracheomalacia and bronchomalacia. Arch Otolaryngol Head Neck Surg. 1999;125(2):203–207.
  9. Vondrys D, Elliott MJ, McLaren CA, Noctor C, Roebuck DJ. First experience with biodegradable airway stents in children. Ann Thorac Surg. 2011;92(5):1870–1874.
  10. Anton-Pacheco JL, Luna C, Garcıa E, et al. Initial experience with a new biodegradable airway stent in children: Is this the stent we were waiting for? Pediatric Pulmonology. 2016;51(6):607–612.
  11. Anton-Pacheco JL, Comas JV, Luna C, et al. Treatment strategies in the management of severe complications following slide tracheoplasty in children. Eur J Cardiothorac Surg. 2014;46(2):280–285.
  12. Serio P, Fainardi V, Leone R, et al. Tracheobronchial obstruction: Follow-up study of 100 children treated with airway stenting. Eur J Cardiothorac Surg. 2014;45(4):100–109.
  13. Zilberman M, Nelson KD, Eberhart RC. Mechanical properties and in vitro degradation of bioresorbable fibers and expandable fiber-based stents. J Biomed Mater Res B Appl Biomater. 2005;74(2):792–799.
  14. Kawahara I, Ono S, Maeda K. Biodegradable polydioxanone stent as a new treatment strategy for tracheal stenosis in a rabbit model. J Pediatr Surg. 2016;51(12):1967–1971.
  15. Lischke R, Pozniak J, Vondrys D, Elliott MJ. Novel biodegradable stents in the treatment of bronchial stenosis after lung transplantation. Eur J Cardiothorac Surg. 2011;40(3):619–624.
  16. Gnagi SH, White DR. Beyond dilation: Current concepts in endoscopic airway stenting and reconstruction. Curr Opin Otolaryngol Head Neck Surg. 2016;24(6):516–521.
  17. Zając A, Krysta M, Tomasik P, Górecki W. First experience with biodegradable airway stents in children – case report. Pediatr Pol. 2017;92(5):615–618.
  18. Sztano B, Kiss G, Marai K, et al. Biodegradable airway stents in infants – potential life-threatening pitfalls. Int J Pediatr Otorhinolaryngol. 2016;91:86–89.